Testing new antibacterial agents against harmful bacteria
Official title: Task A28: In Vitro Screening for Antibacterial Activity Against Disease Pathogens
Funded at Jmi Laboratories · NIH-11178797 · Data updated 2026-11-12
This study is testing new antibacterial treatments in the lab to see how well they can fight off harmful bacteria and their toxins, which could help develop better options for people dealing with infections that don't respond to regular antibiotics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jmi Laboratories NIH-funded |
| Lab location | 1 site (North Liberty, United States) |
| Project start | August 14, 2024 |
| Project end | August 13, 2025 |
| Funding year | 2024 |
| Award (this year) | $70,000 |
| NIH project number | 75N93019D00011-0-759302400002-1 |
| Project ID | NIH-11178797 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.
✕Less likely to help
Patients with infections that are not caused by antibiotic-resistant bacteria may not receive any benefit from this research.
What this research studies
This research focuses on evaluating the effectiveness of new antibacterial agents in laboratory settings to combat various disease-causing bacteria. By conducting in vitro tests, the research aims to determine how well these agents can neutralize toxins produced by bacteria, which is crucial for developing effective treatments. The study also involves maintaining bacterial and toxin samples and creating assays to measure the agents' efficacy. Patients may benefit from the findings as they could lead to new treatments for infections caused by antibiotic-resistant bacteria.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for infections caused by antibiotic-resistant bacteria.
How similar studies have gone: Other research has shown success in developing new antibacterial agents through similar in vitro testing approaches.
Where this research is happening
-
Jmi Laboratories
North Liberty, United States Active
Researchers
- Principal investigator: Arends, Ryan — Jmi Laboratories
- Study coordinator: Arends, Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.